Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

May 4, 2026

Study Completion Date

June 18, 2027

Conditions
Crohn's Disease
Interventions
DRUG

AZD7798

AZD7798

OTHER

Placebo

Placebo

Trial Locations (22)

3000

RECRUITING

Research Site, Leuven

17176

RECRUITING

Research Site, Stockholm

20089

RECRUITING

Research Site, Rozzano

21029

NOT_YET_RECRUITING

Research Site, Vinnytsia

35121

RECRUITING

Research Site, Padua

41345

WITHDRAWN

Research Site, Gothenburg

00168

RECRUITING

Research Site, Roma

1081 HV

RECRUITING

Research Site, Amsterdam

6525 GA

RECRUITING

Research Site, Nijmegen

91-495

RECRUITING

Research Site, Lodz

60-324

RECRUITING

Research Site, Poznan

60-529

RECRUITING

Research Site, Poznan

04-501

RECRUITING

Research Site, Warsaw

52-210

RECRUITING

Research Site, Wroclaw

581 85

RECRUITING

Research Site, Linköping

02002

RECRUITING

Research Site, Kyiv

04210

RECRUITING

Research Site, Kyiv

B15 2GW

RECRUITING

Research Site, Birmingham

CB2 0XY

RECRUITING

Research Site, Cambridge

E1 1BB

RECRUITING

Research Site, London

NW10 7NS

RECRUITING

Research Site, London

WC1E 6AG

RECRUITING

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY